Can a smartphone app break the stigma around depression in black communities?
NCT ID NCT06316804
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a video-based mobile app designed to reduce mental health stigma and medical mistrust among Black adults with moderate to severe depression or anxiety. Participants watch personal stories from others with similar experiences. The goal is to see if this approach is feasible and helps people seek care. The trial enrolls 90 Black adults aged 18-45 who own a smartphone and have not seen a mental health professional in the past year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
video-based mobile app with personal narratives
What this could lead to
If successful, this could point toward a scalable, low-cost tool to reduce stigma and improve mental health care access for Black adults.
What could go wrong
This is a small feasibility study (90 participants) with no control group, so results may not generalize. The intervention is behavioral and effects may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States